Atherogenesis: current understanding of the causes of atheroma.
作者信息
Weissberg P L
机构信息
School of Clinical Medicine, University of Cambridge, Cambridge, UK.
出版信息
Heart. 2000 Feb;83(2):247-52. doi: 10.1136/heart.83.2.247.
Abstract
摘要
相似文献
1
Atherogenesis: current understanding of the causes of atheroma.
Heart. 2000 Feb;83(2):247-52. doi: 10.1136/heart.83.2.247.
2
The role of myocardial perfusion imaging in vascular endothelial dysfunction.
J Nucl Cardiol. 2000 Mar-Apr;7(2):180-4. doi: 10.1016/s1071-3581(00)90042-4.
3
[Vascular endothelium dysfunction as the first phase of arteriosclerosis].
Nihon Naika Gakkai Zasshi. 2007 Aug 10;96(8):1717-23. doi: 10.2169/naika.96.1717.
4
Testing endothelial vasomotor function: nitric oxide, a multipotent molecule.
Circulation. 2003 Oct 28;108(17):2049-53. doi: 10.1161/01.CIR.0000089507.19675.F9.
5
Control of the human cardiovascular system by nitric oxide.
J Hum Hypertens. 1996 Jun;10(6):377-81.
6
[Endothelial function].
Nihon Rinsho. 2006 Aug;64 Suppl 6:166-70.
7
Endothelium, for example.
J R Coll Physicians Lond. 1996 Jan-Feb;30(1):42-51.
8
The Mikamo Lecture 2002. Therapeutic targets for the treatment of atherothrombosis in the new millennium--clinical frontiers in atherosclerosis research.
Circ J. 2002 Sep;66(9):783-90. doi: 10.1253/circj.66.783.
9
Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia.
Mayo Clin Proc. 2001 Jun;76(6):619-31. doi: 10.4065/76.6.619.
10
Endothelial function: a critical determinant in atherosclerosis?
Circulation. 2004 Jun 1;109(21 Suppl 1):II27-33. doi: 10.1161/01.CIR.0000129501.88485.1f.
引用本文的文献
1
Peripheral Arterial Disease in Diabetic Foot: One Disease with Multiple Patterns.
J Clin Med. 2025 Mar 14;14(6):1987. doi: 10.3390/jcm14061987.
2
Administration of the K channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice.
Front Pharmacol. 2025 Feb 28;16:1545050. doi: 10.3389/fphar.2025.1545050. eCollection 2025.
3
Current Understanding of the Pivotal Role of Mitochondrial Dynamics in Cardiovascular Diseases and Senescence.
Front Cardiovasc Med. 2022 May 18;9:905072. doi: 10.3389/fcvm.2022.905072. eCollection 2022.
4
CircRNA-miRNA interactions in atherogenesis.
Mol Cell Biochem. 2022 Dec;477(12):2703-2733. doi: 10.1007/s11010-022-04455-8. Epub 2022 May 23.
5
Human coronary microvascular contractile dysfunction associates with viable synthetic smooth muscle cells.
Cardiovasc Res. 2022 Jun 29;118(8):1978-1992. doi: 10.1093/cvr/cvab218.
6
Neutrophil to lymphocyte ratio is associated with proximal/middle segment of the LAD lesions in patients with ST segment elevation infarction.
Cent Eur J Immunol. 2016;41(4):386-391. doi: 10.5114/ceji.2016.65138. Epub 2017 Jan 24.
7
The Role of IL-33 in the Inflammation Process of Asthma and Atherosclerosis.
EJIFCC. 2011 Oct 5;22(3):79-91. eCollection 2011 Oct.
8
CRP and IL-1B Gene Polymorphisms and CRP in Blood in Periodontal Disease.
Open Dent J. 2013 Jul 26;7:88-93. doi: 10.2174/1874210601307010088.
9
Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease.
Clin Res Cardiol. 2012 Apr;101(4):247-53. doi: 10.1007/s00392-011-0386-0. Epub 2011 Nov 25.
10
Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.
Br J Pharmacol. 2009 Mar;156(5):689-712. doi: 10.1111/j.1476-5381.2008.00047.x. Epub 2009 Feb 23.
本文引用的文献
1
Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.
N Engl J Med. 1998 Dec 31;339(27):1972-8. doi: 10.1056/NEJM199812313392703.
2
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.
JAMA. 1998 May 27;279(20):1643-50. doi: 10.1001/jama.279.20.1643.
3
Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques.
Circ Res. 1998 Apr 6;82(6):704-12. doi: 10.1161/01.res.82.6.704.
4
Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo.
Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):333-8. doi: 10.1161/01.atv.18.3.333.
5
Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.
J Am Coll Cardiol. 1998 Mar 1;31(3):684-91. doi: 10.1016/s0735-1097(97)00537-8.
6
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
N Engl J Med. 1997 Apr 3;336(14):973-9. doi: 10.1056/NEJM199704033361401.
7
Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.
Circulation. 1996 Oct 15;94(8):2013-20. doi: 10.1161/01.cir.94.8.2013.
8
Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis.
Semin Thromb Hemost. 1996;22(2):139-44. doi: 10.1055/s-2007-999001.
9
Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo.
Circulation. 1996 Sep 1;94(5):932-8. doi: 10.1161/01.cir.94.5.932.
10
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.
N Engl J Med. 1995 Feb 23;332(8):481-7. doi: 10.1056/NEJM199502233320801.
Zotero 插件